| 标题 |
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Paolo A. Ascierto; Daniil Stroyakovskiy; Helen Gogas; Caroline Robert; Karl D. Lewis; et al 出版日期:2022-11-30 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)